544205 — National Peroxide Cashflow Statement
0.000.00%
- IN₹3.36bn
- IN₹2.99bn
- IN₹3.33bn
- 48
- 39
- 12
- 22
Annual cashflow statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Net Income/Starting Line | 535 | 215 |
Depreciation | ||
Non-Cash Items | 32 | -13.2 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | -93.9 | -30.5 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Other Assets | ||
Change in Accounts Payable | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | 671 | 364 |
Capital Expenditures | -59.9 | -146 |
Purchase of Fixed Assets | ||
Other Investing Cash Flow Items | 308 | -28.8 |
Sale of Fixed Assets | ||
Sale/Maturity of Investment | ||
Change in Net Investments | ||
Purchase of Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | 248 | -175 |
Financing Cash Flow Items | -63 | -27.1 |
Other Financing Cash Flow | ||
Total Cash Dividends Paid | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | -860 | -167 |
Foreign Exchange Effects | ||
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 59.3 | 21.8 |